Heart Failure Reviews

Heart Failure Reviews

心力衰竭评论

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Heart Failure Reviews》是由Springer US出版社于1996年创办的英文国际期刊(ISSN: 1382-4147,E-ISSN: 1573-7322),该期刊长期致力于心脏和心血管系统领域的创新研究,主要研究方向为医学-心血管系统。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.1640...%),以发表心脏和心血管系统领域等方向的原创性研究为核心(研究类文章占比48.78%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在82篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Heart Failure Reviews审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约82篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 82 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q1 44 / 220

80.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q1 47 / 220

78.86%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:10.4 SJR:1.208 SNIP:1.221
学科类别 分区 排名 百分位
大类:Medicine 小类:Cardiology and Cardiovascular Medicine Q1 36 / 387

90%

期刊发文

  • Cognitive impairment in patients with heart failure: molecular mechanism and therapy

    Author: Wu, Yanan; Chen, Liwen; Zhong, Feng; Zhou, Kaiyi; Lu, Chao; Cheng, Xiao; Wang, Sheng

    Journal: HEART FAILURE REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10741-022-10289-9

  • A conversion CRT strategy combined with AVJA may be a perspective alternative for heart failure patients with persistent atrial fibrillation

    Author: Chen, Mengna; Dong, Zhiqiang; Zhang, Yimin; Liu, Jieyun; Zhang, Junmeng

    Journal: HEART FAILURE REVIEWS. 2023; Vol. 28, Issue 2, pp. 367-377. DOI: 10.1007/s10741-023-10294-6

  • Changes of energy metabolism in failing heart and its regulation by SIRT3

    Author: Wang, Xiao; Huang, Yuting; Zhang, Kai; Chen, Feng; Nie, Tong; Zhao, Yun; He, Feng; Ni, Jingyu

    Journal: HEART FAILURE REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10741-023-10295-5

  • Advances in novel devices for the treatment of heart failure

    Author: Tang, Renjie; Chang, Yuan; Song, Jiangping

    Journal: HEART FAILURE REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10741-022-10293-z

  • The phagocytic role of macrophage following myocardial infarction

    Author: Li, Jiahua; Chen, Qi; Zhang, Rong; Liu, Zhongqiu; Cheng, Yuanyuan

    Journal: HEART FAILURE REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10741-023-10314-5

  • Comparison of American and European guidelines for cardio-oncology of heart failure

    Author: Chen, Jun-Zhang; Liang, Bo

    Journal: HEART FAILURE REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10741-023-10304-7

  • Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis

    Author: Yangjing Xue, Jinsheng Wang, Jiaoni Wang, Saroj Thapa, Kaiyu Huang, Yangpei Peng, Lu Qian, Jiwu Li, Kangting Ji

    Journal: HEART FAILURE REVIEWS, 2019, Vol., , DOI:10.1007/s10741-018-9761-5

  • Protective role of beta-blockers in chemotherapy-induced cardiotoxicity—a systematic review and meta-analysis of carvedilol

    Author: Shan Huang, Qin Zhao, Zhi-gang Yang, Kai-yue Diao, Yong He, Ke Shi, Meng-ting Shen, Hang Fu, Ying-kun Guo

    Journal: HEART FAILURE REVIEWS, 2018, Vol., , DOI:10.1007/s10741-018-9755-3